Administrative litigation on unfair reimbursement price reduction

Pharmaceutical business sources say that the third-round administrative litigation designed to invalidate some items for which reduction in reimbursement price was unilaterally made by the government, will be first examined by Seoul District Court from January 24.

The administrative litigation will focus on whether the claims of some pharmaceutical firms who are an eligible plaintiff of this...